MACUSTAR

Official title: Development of novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention in patients with intermediate age-related macular degeneration (AMD)

Trial start year: 2018

Trial website

www.macustar.eu
View website

Trial registration

NCT03349801
View registration

Design paper

2020

Clinical study protocol for a lowinterventional study in intermediate agerelated macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention - MACUSTAR
Download full paper

Result paper

No result paper published